Screener
Indivior Pharmaceuticals, Inc. INDV Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
FAQ
- What is Indivior Pharmaceuticals, Inc.'s total cost of revenue?
- Indivior Pharmaceuticals, Inc. (INDV) reported total cost of revenue of $40M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s total cost of revenue changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s total cost of revenue decreased by 9.1% year-over-year, from $44M to $40M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s total cost of revenue?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s total cost of revenue has grown at a 17.7% compound annual growth rate (CAGR), from $151M to $246M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Indivior Pharmaceuticals, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude